Treatment for the endocrine resistant breast cancer: Current options and future perspectives

被引：36
|
作者：
Liu, Chun-Yu [1 ,3 ]
Wu, Chia-Yun [1 ,3 ]
Petrossian, Karineh [4 ]
Huang, Tzu-Ting [1 ]
Tseng, Ling-Ming [2 ,3 ]
Chen, Shiuan [4 ]
机构：
[1] Dept Oncol, Div Med Oncol, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan
[3] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan
[4] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, 1500 East Duarte Rd, Duarte, CA 91010 USA
来源：
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 2017年 / 172卷
关键词：
Endocrine resistance; Hormone receptor; Estrogen receptor; Breast cancer; ESTROGEN-RECEPTOR-ALPHA; GROWTH-FACTOR RECEPTOR; NONSTEROIDAL AROMATASE INHIBITORS; EVEROLIMUS PLUS EXEMESTANE; PENTOSE-PHOSPHATE PATHWAY; RANDOMIZED PHASE-II; HORMONE-RECEPTOR; POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; TAMOXIFEN RESISTANCE;
D O I：
10.1016/j.jsbmb.2017.07.001
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Endocrine resistance remains a challenge and an unmet need for managing hormone receptor-positive breast cancer. The mechanisms of endocrine resistance are multifaceted and are likely to evolve over time following various single or combination therapies. The purpose of this review article is to provide general understanding of molecular basis of endocrine resistance of breast cancer and to offer comprehensive review on current treatment options and potential new treatment strategies for endocrine resistant breast cancers. Last but not the least, we discuss current challenges and future directions for management of endocrine resistant breast cancers.
引用
收藏
页码：166 / 175
页数：10
相关论文
共 50 条
  • [11] Breast cancer: Current and future endocrine therapies
    Palmieri, Carlo
    Patten, Darren K.
    Januszewski, Adam
    Zucchini, Giorgia
    Howell, Sacha J.
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2014, 382 (01) : 695 - 723
  • [12] Treatment options in patients with metastatic gastric cancer:Current status and future perspectives
    Ahmet Bilici
    [J]. World Journal of Gastroenterology, 2014, (14) : 3905 - 3915
  • [13] Treatment options in patients with metastatic gastric cancer: Current status and future perspectives
    Bilici, Ahmet
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (14) : 3905 - 3915
  • [14] Current treatment options and future perspectives on first line metastatic bladder cancer
    Campanario Perez, Ruben
    Campanario Perez, Francisco
    [J]. ARCHIVOS ESPANOLES DE UROLOGIA, 2020, 73 (10): : 996 - 1006
  • [15] A review of endocrine options for the treatment of advanced breast cancer
    Kaufmann, M
    [J]. ONCOLOGY, 1997, 54 : 2 - 5
  • [16] Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives
    Koustas, Evangelos
    Trifylli, Eleni-Myrto
    Sarantis, Panagiotis
    Papadopoulos, Nikolaos
    Karapedi, Eleni
    Aloizos, Georgios
    Damaskos, Christos
    Garmpis, Nikolaos
    Garmpi, Anna
    Papavassiliou, Kostas A.
    Karamouzis, Michalis V.
    Papavassiliou, Athanasios G.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
  • [17] Second-line Treatment of Advanced Gastric Cancer: Current Options and Future Perspectives
    Chrom, Pawel
    Stec, Rafal
    Szczylik, Cezary
    [J]. ANTICANCER RESEARCH, 2015, 35 (09) : 4575 - 4583
  • [18] Gallbladder cancer: current and future treatment options
    Zhou, Yanzhao
    Yuan, Kun
    Yang, Yi
    Ji, Zemin
    Zhou, Dezheng
    Ouyang, Jingzhong
    Wang, Zhengzheng
    Wang, Fuqiang
    Liu, Chang
    Li, Qingjun
    Zhang, Qi
    Li, Qiang
    Shan, Xiao
    Zhou, Jinxue
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [19] Current treatment options for inflammatory breast cancer
    Singletary, SE
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1999, 6 (03) : 228 - 229
  • [20] Current perspectives for treatment of breast cancer
    Bunnell C.
    [J]. Breast Cancer, 2000, 7 (4) : 380 - 388
12345